Skip to main content
. 2021 Dec 1;6(6):e00711-21. doi: 10.1128/mSphere.00711-21

FIG 6.

FIG 6

Similarity of microbiome-derived metabolites to synthetic antivirals. Microbiome-derived antiviral metabolites structurally and/or functionally resemble synthetic molecules that have been clinically explored for anti-SARS-CoV-2 activity.